Remedy Meds tirzepatide review
Advertised at $279, billed at $399. Position 18 of 20 on our board.
Updated 2026-09-18
$399 a month flat at every dose, which is the right structure at roughly triple the board floor.
First month $279, renewing at $399. Medication included in the fee, unlimited clinician access and dose adjustments included.
The numbers
| Remedy Meds · tirzepatide | |
|---|---|
| Advertised | $279/mo |
| Membership | None |
| Billed | $399/mo |
| Advertised-to-billed gap | +$120/mo |
| Per year | $4,788 |
| Board position | 18 of 20, cheapest first |
The $279 is a first-month rate; it renews at $399. Flat across every dose, which benefits anyone titrating high.
Where the gap is
$120 between the first month and the renewal. Disclosed, but it is the figure people budget from and then get wrong.
Against the board
About $4,788 a year at the recorded rate. Trimi is $1,500 and Coreage Rx is $1,548 on its twelve-month tirzepatide plan. These are comparisons of cost and commitment, not proof of equivalent care.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $129 | $199 | +$70 | +$74/mo |
| SuperHealthy Rx | $135 | $135 | none | +$10/mo |
| Likeness Rx | $129 | $199 | +$70 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
How the programme works
Compounded GLP-1 programme with two flat monthly prices that do not change with dose, medication included in the monthly fee.
Verified facts
- Compounded semaglutide priced at $299/month flat, regardless of dose.
- Compounded tirzepatide priced at $399/month flat, regardless of dose.
- First month of tirzepatide discounted to $279, then $399/month.
- Medication is included in the monthly fee rather than billed separately.
- Unlimited clinician access, check-ins and dose adjustments included.
- Branded Zepbound offered at around $1,399/month.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
- Unlimited clinician access is included rather than sold as an upgrade.
- Medication is inside the monthly fee, so there is no second bill.
Against it
- Expensive relative to the flat-rate leaders for the same class of medication.
- The $279 first month steps up to $399 on renewal.
Read this bit. The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 2.9 / 5 |
| Price honesty | 20% | 4 / 5 |
| Clinical support | 20% | 4 / 5 |
| Pharmacy sourcing | 15% | 3.5 / 5 |
| Cancelling | 15% | 3.4 / 5 |
Verdict
Good structure, high number, honest about both. Budget from $399, not $279.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $129, billed at $199. Position 1 of 20 on our board.
- Likeness Rx tirzepatide review
Advertised at $129, billed at $199. Position 3 of 20 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $139/mo semaglutide.
- Six fee traps
Compare the product, supply period, recurring charge and commitment before treating a headline as the full bill.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure